236 related articles for article (PubMed ID: 26116610)
1. Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass.
Xiao W; Beibei F; Guangsi S; Yu J; Wen Z; Xi H; Youjia X
J Endocrinol; 2015 Sep; 226(3):121-34. PubMed ID: 26116610
[TBL] [Abstract][Full Text] [Related]
2. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species.
Jia P; Xu YJ; Zhang ZL; Li K; Li B; Zhang W; Yang H
J Orthop Res; 2012 Nov; 30(11):1843-52. PubMed ID: 22570238
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
[TBL] [Abstract][Full Text] [Related]
4. Iron-induced oxidative stress stimulates osteoclast differentiation via NF-κB signaling pathway in mouse model.
Wang X; Chen B; Sun J; Jiang Y; Zhang H; Zhang P; Fei B; Xu Y
Metabolism; 2018 Jun; 83():167-176. PubMed ID: 29378199
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of deferoxamine on iron overload-induced inhibition of osteogenesis in a zebrafish model.
Chen B; Yan YL; Liu C; Bo L; Li GF; Wang H; Xu YJ
Calcif Tissue Int; 2014 Mar; 94(3):353-60. PubMed ID: 24414856
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
7. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Hughes A; Rogers MJ; Idris AI; Crockett JC
Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
[TBL] [Abstract][Full Text] [Related]
10. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
Stubelius A; Andersson A; Holmdahl R; Ohlsson C; Islander U; Carlsten H
BMC Musculoskelet Disord; 2016 Nov; 17(1):464. PubMed ID: 27829407
[TBL] [Abstract][Full Text] [Related]
11. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
12. Ionizing Radiation Exacerbates the Bone Loss Induced by Iron Overload in Mice.
Zhang J; Qiao P; Yao G; Zhao H; Wu Y; Wu S
Biol Trace Elem Res; 2020 Aug; 196(2):502-511. PubMed ID: 31691189
[TBL] [Abstract][Full Text] [Related]
13. Bone metabolism and oxidative stress in postmenopausal rats with iron overload.
Isomura H; Fujie K; Shibata K; Inoue N; Iizuka T; Takebe G; Takahashi K; Nishihira J; Izumi H; Sakamoto W
Toxicology; 2004 Apr; 197(2):93-100. PubMed ID: 15003320
[TBL] [Abstract][Full Text] [Related]
14. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
15. Bone-cell changes in estrogen-induced bone-mass increase in mice: dissociation of osteoclasts from bone surfaces.
Liu CC; Howard GA
Anat Rec; 1991 Feb; 229(2):240-50. PubMed ID: 2012311
[TBL] [Abstract][Full Text] [Related]
16. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
17. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
[TBL] [Abstract][Full Text] [Related]
18. Positive regulation of osteogenesis by bile acid through FXR.
Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
[TBL] [Abstract][Full Text] [Related]
19. Do effects of propranolol on the skeletal system depend on the estrogen status?
Sliwiński L; Folwarczna J; Pytlik M; Cegieła U; Nowińska B; Trzeciak H; Trzeciak HI
Pharmacol Rep; 2013; 65(5):1345-56. PubMed ID: 24399731
[TBL] [Abstract][Full Text] [Related]
20. Effect of Rehmannia glutinosa Libosch extracts on bone metabolism.
Oh KO; Kim SW; Kim JY; Ko SY; Kim HM; Baek JH; Ryoo HM; Kim JK
Clin Chim Acta; 2003 Aug; 334(1-2):185-95. PubMed ID: 12867291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
